Coverage
-
August 14, 2013
Avanir Pharmaceuticals Inc. has settled a suit in Delaware federal court accusing Sandoz Inc.'s planned generic version of involuntary-emotion treatment Nuedexta of infringing three patents, the company announced Wednesday.
1 other articles on this case.
View all »